UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Orthanq: transparent and uncertainty-aware haplotype quantification with application in HLA-typing

BMC bioinformatics, 2024-07, Vol.25 (1), p.1-18, Article 240

2024

Volltextzugriff (PDF)

Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30

Cancer research (Chicago, Ill.), 2014-07, Vol.74 (13), p.3429-3440

2014

Volltextzugriff (PDF)

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

Nature communications, 2017-05, Vol.8 (1), p.15440-15440, Article 15440

2017

Volltextzugriff (PDF)

Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance

JNCI : Journal of the National Cancer Institute, 2018-06, Vol.110 (6), p.677-681

2018

Volltextzugriff (PDF)

Cytotoxic CD4 + T cells in chronic viral infections and cancer

Frontiers in immunology, 2023-10, Vol.14, p.1271236-1271236

2023

Volltextzugriff (PDF)

Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma

Scientific reports, 2017-05, Vol.7 (1), p.2290-11, Article 2290

2017

Volltextzugriff (PDF)

Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D

Cancer research (Chicago, Ill.), 2012-01, Vol.72 (2), p.460-471

2012

Volltextzugriff (PDF)

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

International journal of cancer, 2013-10, Vol.133 (7), p.1653-1663

2013

Volltextzugriff (PDF)

Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes

Cancer Immunology, Immunotherapy, 2012-09, Vol.61 (9), p.1359-1371

2012

Volltextzugriff (PDF)

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

Journal of Virology, 2009-08, Vol.83 (16), p.8108-8121

2009

Volltextzugriff (PDF)

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

The Journal of clinical investigation, 2009-05, Vol.119 (5), p.1251-1263

2009

Volltextzugriff (PDF)

The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

Cell reports (Cambridge), 2019-06, Vol.27 (12), p.3573-3586.e7

2019

Volltextzugriff (PDF)

Direct RIG‐I activation in human NK cells induces TRAIL‐dependent cytotoxicity toward autologous melanoma cells

International journal of cancer, 2019-04, Vol.144 (7), p.1645-1656

2019

Volltextzugriff (PDF)

Persister state-directed transitioning and vulnerability in melanoma

Nature communications, 2022-06, Vol.13 (1), p.3055-3055, Article 3055

2022

Volltextzugriff (PDF)

Innate RIG-I signaling restores antigen presentation in tumors and overcomes T cell resistance

Cell Stress, 2021-01, Vol.5 (2), p.26-28

2021

Volltextzugriff (PDF)

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors

Frontiers in immunology, 2023-02, Vol.14, p.1119498-1119498

2023

Volltextzugriff (PDF)

Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells

Biomedicine & pharmacotherapy, 2023-12, Vol.168, p.115635-115635, Article 115635

2023

Volltextzugriff (PDF)

Clinical and genetic analysis of melanomas arising in acral sites

European journal of cancer (1990), 2019-09, Vol.119, p.66-76

2019

Volltextzugriff (PDF)

Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma

Journal of nanobiotechnology, 2018-05, Vol.16 (1), p.47-47, Article 47

2018

Volltextzugriff (PDF)

Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors

Oncoimmunology, 2018-02, Vol.7 (2), p.e1392426-e1392426

2018

Volltextzugriff (PDF)

Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B

Clinical cancer research, 2009-08, Vol.15 (16), p.5208-5215

2009

Volltextzugriff (PDF)

Targeting the melanoma-associated antigen CSPG4 with HLA-C07:01-restricted T-cell receptors

Frontiers in immunology, 2023-10, Vol.14, p.1245559-1245559

2023

Volltextzugriff (PDF)

Dacarbazine in Melanoma: From a Chemotherapeutic Drug to an Immunomodulating Agent

Journal of investigative dermatology, 2013-02, Vol.133 (2), p.289-292

2013

Volltextzugriff (PDF)

Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma

Frontiers in immunology, 2024-06, Vol.15, p.1383125

2024

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)

Publikationsform

Artikel
(114)
Buchkapitel
(2)

Sprache

Englisch
(116)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Orthanq: transparent and uncertainty-aware haplotype quantification with application in HLA-typing

Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance

Cytotoxic CD4 + T cells in chronic viral infections and cancer

Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma

Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

Direct RIG‐I activation in human NK cells induces TRAIL‐dependent cytotoxicity toward autologous melanoma cells

Persister state-directed transitioning and vulnerability in melanoma

Innate RIG-I signaling restores antigen presentation in tumors and overcomes T cell resistance

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors

Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells

Clinical and genetic analysis of melanomas arising in acral sites

Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma

Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors

Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B

Targeting the melanoma-associated antigen CSPG4 with HLA-C07:01-restricted T-cell receptors

Dacarbazine in Melanoma: From a Chemotherapeutic Drug to an Immunomodulating Agent

Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology

Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma

Aktive Filter

Suchergebnisse filtern